http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20040101335-A
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-74 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 |
filingDate | 2003-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2004-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | KR-20040101335-A |
titleOfInvention | Lactobacillus strains |
abstract | The present invention is a novel Lactobacillus strain Lba EB01 (DSM 14869), Lactobacillus paracasei, which are novel Lactobacillus strains that can be used alone or in combination as probiotics or as synthetic biologics with prebiotics. Strain Lbp PB01 (DSM 14870), Lactobacillus asidophilus strain Lba EB02 (DSM 15525), Lactobacillus plantarum strain Lbpl PB02 (DSM 15524), Lactobacillus strain Lbxx EB03 (DSM 15527), Lactobacillus strain Lbxx PB03 (DSM 15526) and Lactobacillus strains having essentially the same properties. The invention also provides for the use of strains for the prevention or treatment of vaginal infections, urogenital infections and gastrointestinal diseases, as well as pharmaceutical compositions, dairy products, functional foods, nutraceuticals and personal health care comprising the strains alone or in combination. To provide products. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101398347-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102063757-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018021874-A1 |
priorityDate | 2002-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 93.